大型制药公司寻找新冠肺炎疫苗:达到极限!

Q2 Engineering
J. Segers, E. Gaile-Sarkane
{"title":"大型制药公司寻找新冠肺炎疫苗:达到极限!","authors":"J. Segers, E. Gaile-Sarkane","doi":"10.24840/2183-0606_009.002_0001","DOIUrl":null,"url":null,"abstract":"The 2020 COVID-19 pandemic undermines the world economy, the affordability and accessibility of our health systems. It puts an increasing strain on global production, supply and value chains. The research and development of a set of COVID-19 vaccines is an unprecedented triumph of rapid innovation. The sense of urgency has prompted academic research institutions, big pharmaceuticals and dedicated biotechnology companies to develop vaccines targeting the SARS-CoV-2 coronavirus disease. Simultaneously, it unlocks new value for business, patients and society. Consequently, new business models have come to the forefront.","PeriodicalId":33389,"journal":{"name":"Journal of Innovation Management","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Big pharma’s search for a COVID-19 vaccine: Take It To The Limit!\",\"authors\":\"J. Segers, E. Gaile-Sarkane\",\"doi\":\"10.24840/2183-0606_009.002_0001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The 2020 COVID-19 pandemic undermines the world economy, the affordability and accessibility of our health systems. It puts an increasing strain on global production, supply and value chains. The research and development of a set of COVID-19 vaccines is an unprecedented triumph of rapid innovation. The sense of urgency has prompted academic research institutions, big pharmaceuticals and dedicated biotechnology companies to develop vaccines targeting the SARS-CoV-2 coronavirus disease. Simultaneously, it unlocks new value for business, patients and society. Consequently, new business models have come to the forefront.\",\"PeriodicalId\":33389,\"journal\":{\"name\":\"Journal of Innovation Management\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Innovation Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24840/2183-0606_009.002_0001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Engineering\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Innovation Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24840/2183-0606_009.002_0001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Engineering","Score":null,"Total":0}
引用次数: 1

摘要

2020年新冠肺炎疫情破坏了世界经济、我们卫生系统的负担能力和可及性。它给全球生产、供应和价值链带来了越来越大的压力。一套新冠肺炎疫苗的研发是快速创新的前所未有的胜利。这种紧迫感促使学术研究机构、大型制药公司和专门的生物技术公司开发针对严重急性呼吸系统综合征冠状病毒2型的疫苗。同时,它为企业、患者和社会释放了新的价值。因此,新的商业模式走到了最前沿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Big pharma’s search for a COVID-19 vaccine: Take It To The Limit!
The 2020 COVID-19 pandemic undermines the world economy, the affordability and accessibility of our health systems. It puts an increasing strain on global production, supply and value chains. The research and development of a set of COVID-19 vaccines is an unprecedented triumph of rapid innovation. The sense of urgency has prompted academic research institutions, big pharmaceuticals and dedicated biotechnology companies to develop vaccines targeting the SARS-CoV-2 coronavirus disease. Simultaneously, it unlocks new value for business, patients and society. Consequently, new business models have come to the forefront.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Innovation Management
Journal of Innovation Management Engineering-Engineering (miscellaneous)
CiteScore
3.50
自引率
0.00%
发文量
21
审稿时长
25 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信